Ursolic Acid Inhibits Tumor Growth via Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cells

被引：23
|
作者：
Wang, Xianmin [1 ]
Wang, Ting [2 ]
Yi, Fan [3 ]
Duan, Chunyan [4 ]
Wanwg, Qiaoling [4 ]
He, Nana [4 ]
Zhu, Lei [5 ]
Li, Qi [2 ]
Deng, Wanli [2 ,4 ]
机构：
[1] Xinjiang Med Univ, Tradit Chinese Med Hosp Affiliated, Dept Tradit Chinese Med, Xinjiang 830000, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China
[3] Urumqi Hosp Tradit Chinese Med, Dept Digest Dis, Urumqi 830000, Xinjiang, Peoples R China
[4] Xinjiang Med Univ, Tradit Chinese Med Hosp Affiliated, Oncol Dept 1, Xinjiang 830000, Peoples R China
[5] Changji Tradit Chinese Med Hosp Xinjiang, Dept Internal Med 4, Xinjiang 830054, Peoples R China
来源：
BIOLOGICAL & PHARMACEUTICAL BULLETIN | 2019年 / 42卷 / 05期
基金：
中国国家自然科学基金;
关键词：
colorectal cancer; epithelial-mesenchymal transition; metastasis; ursolic acid; invasion; DERIVATIVES; CHEMOSENSITIZATION; PROLIFERATION; METASTASIS;
D O I：
10.1248/bpb.b18-00613
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Ursolic acid (UA), a natural pentacyclic triterpenoid, is a promising compound for cancer prevention and therapy. However, its mechanisms of action have not been well elucidated in colorectal cancer cells. Here, using cultured human colon cancer cell lines SW620 and HCT116, this assay demonstrates that UA reduces cell viability, inhibits cell clone formation, and induces caspase-3 mediated apoptosis. Additional experiments show that UA inhibits cell migration and epithelial-mesenchymal transition (EMT), including E-cadherin, Vimentin, Integrin, Twist, and Zeb1 biomakers. These results suggest that UA inhibits cell proliferation, invasion, and metastasis in colorectal cancer cells by affecting mechanisms that regulate EMT. Taken together, the results suggested that the anti-proliferation and anti-metastasis activities of UA was through EMT inhibition in colorectal cancer.
引用
收藏
页码：685 / 691
页数：7
相关论文
共 50 条
  • [1] Role of epithelial-to-mesenchymal transition and cancer stem cells in colorectal cancer
    Fudalej, Marta
    Mormul, Agata
    Deptala, Andrzej
    Badowska-Kozakiewicz, Anna M.
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [2] Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis
    Vardas, Vasileios
    Politaki, Eleni
    Pantazaka, Evangelia
    Georgoulias, Vassilis
    Kallergi, Galatea
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2022, 66 (1-3): : 277 - 283
  • [3] Anti-Tumor Effects of Paeoniflorin on Epithelial-To-Mesenchymal Transition in Human Colorectal Cancer Cells
    Zhang, Zia-Wei
    Li, Li-Xin
    Wu, Wei-Zhong
    Pan, Ting-Jia
    Yang, Zhao-Shuo
    Yang, Yun-Ke
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 6405 - 6413
  • [4] Oxaliplatin resistance in colorectal cancer cells induces epithelial-to-mesenchymal transition
    Yang, AD
    Fan, F
    Camp, ER
    Somcio, RJ
    Gray, MJ
    Liu, W
    Ellis, LM
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 6 - 6
  • [5] Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway
    Shao, Minghai
    Jiang, Caiping
    Yu, Changhui
    Jia, Haijian
    Wang, Yanli
    Mao, Xinli
    [J]. ONCOLOGY LETTERS, 2022, 23 (03)
  • [6] Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
    van der Horst, Paul H.
    Wang, Yongyi
    Vandenput, Ingrid
    Kuhne, Liesbeth C.
    Ewing, Patricia C.
    van IJcken, Wilfred F. J.
    van der Zee, Marten
    Amant, Frederic
    Burger, Curt W.
    Blok, Leen J.
    [J]. PLOS ONE, 2012, 7 (01):
  • [7] Pharmacological Targeting of Epithelial-to-Mesenchymal Transition in Colorectal Cancer
    Zafari, Nima
    Velayati, Mahla
    Nassiri, Mohammadreza
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Ferns, Gordon A.
    Avan, Amir
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (28) : 2298 - 2311
  • [8] Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells
    Buhrmann, Constanze
    Brockmueller, Aranka
    Harsha, Choudhary
    Kunnumakkara, Ajaikumar B.
    Kubatka, Peter
    Aggarwal, Bharat B.
    Shakibaei, Mehdi
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition
    Sanookpan, Kittipong
    Nonpanya, Nongyao
    Sritularak, Boonchoo
    Chanvorachote, Pithi
    [J]. MOLECULES, 2021, 26 (03):
  • [10] Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo
    Xu, Chang-Geng
    Zhu, Xia-Lian
    Wang, Wei
    Zhou, Xiang-Jun
    [J]. PHARMACEUTICAL BIOLOGY, 2019, 57 (01) : 169 - 175
12345